Bellevue Group’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,290,278
| Closed | -$5.57M | – | 163 |
|
|
2022
Q4 | $5.57M | Sell |
1,290,278
-1,556,179
| -55% | -$6.72M | 0.07% | 109 |
|
|
2022
Q3 | $21.4M | Buy |
2,846,457
+175,044
| +7% | +$1.32M | 0.31% | 81 |
|
|
2022
Q2 | $26.8M | Buy |
2,671,413
+265,588
| +11% | +$2.67M | 0.38% | 72 |
|
|
2022
Q1 | $29.8M | Buy |
+2,405,825
| New | +$29.8M | 0.35% | 81 |
|